ZF Polpharma SA

ZF Polpharma SA

Sales markets: Western Europe | Eastern Europe | Middle East | Asia | Australia | North America | Africa | Central/South America

About us

Polpharma Group is a high quality European pharma and biotech manufacturer and a reputable business partner for pharmaceutical companies worldwide. We grow our presence through B2B activities, including API custom development and manufacturing in our cGMP-compliant and FDA-approved facility, out-licensing of vertically integrated solutions from API to finished formulation, and contract manufacturing services covering a wide variety of solid and liquid forms. We are also a fully integrated, state-of-the-art biotechnology CDMO player mastering all steps of the industrial value chain from cell line generation via process and product development to biopharmaceutical GMP manufacturing from clinical to commercial scale.




Read more

Meet us at

20 jun 2018

CPhI & PMEC China 2018

20 - 22 June, 2018 Shanghai, China Visit us at stand E1N28 Book a meeting See our Exhibitor Profile
3 sep 2018

CPHI Middle East & Africa 2018

3 - 5 September 2018 Abu Dhabi, UAE Visit us at stand J42 Book a meeting See our Exhibitor Profile
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain Visit us at stand 9F40 Book a meeting See our Exhibitor Profile

News about ZF Polpharma SA

Thank you for being with us at CPhI North America!

4 May 2018

Thank you for being with us at CPhI North America!

Dear Business Partners! Thank you for being with us at CPhI North America 2018! It was delightful time with you, which will bring many new solutions in the future! We are always happy to travel across the world to meet you and discuss our offer.
As your European B2B Partner, we always strive to deliver the best.

Read more

16 Apr 2018

Polpharma B2B at CPhI NA 2018 !Meet us at booth 1049 and be invited to the session „Polpharma B2B – Your European API CDMO and Complex FDF Development Partner”, hosted by Michał Radowski, PhD, Head of B2B Pipeline and Te

Polpharma B2B is the official exhibitor and a Silver Sponsor of the event! Don’t miss this great opportunity to check our unique services dedicated to North America audience.

Read more

2 Jan 2018

Polpharma B2B around the World 2018!

In 2018, we will travel around the world participating in major business events and face-to-face meetings in order to propose the best solutions to your needs and discover further business opportunities. There will be many occasions to tighten our partnership and help your business grow.

To discover more about Polpharma B2B, contact us today.


Read more

19 Dec 2017

The next Polish GMP inspections (MPI) at API plant finished with positive result!

Recently, the Polish Authorities (MPI, Main Pharmaceutical Inspectorate) conducted two inspections at Polpharma API Plant.

Both inspections finished with a positive result, the inspectors will recommend the issue of GMP certificates for all the substances evaluated. This was a further acknowledgment that the API Plant meets GMP requirements, and the certificate makes it possible to sell our products around the world.
This is the best confirmation that We deliver quality.

In September, our recently developed active substances were accepted by MPI:
• Bazedoxifene Acetate
• Brexpiprazole
• Aripiprazole Monohydrate

as well as:
• Piracetam
• Carvedilol
• Tolterodine tartrate
• Carbamazepine
• Pentoxifylline

Moreover, in October MPI approved another 8 active substances from our portfolio:
• Hydrochlorothiazide
• Avanafil
• Alendronate sodium trihydrate
• Eodolac
• Ticagrelor
• Saxagliptin monohydrate
• Zolendronic acid monohydrate
• Metronizadole

Talk with our Sales Team!

Read more


FDF DOssier list / March 2018
catalog | 2018-04-16
API Pipeline / March 2018
catalog | 2018-04-16
API Product List / March 2018
catalog | 2018-04-16
catalog | 2018-04-16